DCVC Bio invests in early-stage deep tech startups in the life sciences, including therapeutics platforms, companies improving agriculture and food systems, and industrial biotechnologies.
2018
Privately held
High, focusing on high-impact, innovative startups.
Palo Alto, Ca, United States
About
Mission
Leverage advanced technologies to transform human health, agriculture, and synthetic biology.
Values
Innovation, sustainability, and advancing basic science and technology.
Participant Demographics
Entrepreneurs and startups in life sciences and deep tech sectors.
Track Record
Team Experience
Team consists of experts in genetics, chemistry, molecular biology, and artificial intelligence.
Notable Achievements
Supported exits like AbCellera (Nasdaq: ABCL), Amplitude (Nasdaq: AMPL), and acquisitions like Agenovir by Vir Biotechnology.
Project Track Record
Notable investments include AbCellera, Umoja Biopharma, and MycoWorks.
Get Full Profile
Access complete investment history, team details, portfolio companies, and direct contact information.
Unlock Full AccessHeadquarters
Palo Alto, Ca, United States
Access 150,000+ investor profiles
Get complete access to our database of investment firms with detailed profiles, contact information, investment preferences, and AI-powered matching.